Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus-Reference-Cited by-同舟云学术

Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus

Published:1990-11 Issue:5 Volume:117 Page:771-776
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Hammerman Cathy,Aramburo Mary Jane

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference22 articles.

1. Incidence and clinical features of patent ductus arteriosus in low birth weight infants: a prospective analysis of 150 consecutively born infants;Siassi;Pediatrics,1976

2. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study;Gersony;J Pediatr,1983

3. Clinical evaluation of premature infants with patent ductus arteriosus;Yeh;Crit Care Med,1981

4. Radioimmunoassay techniques for the determination of the local release of prostaglandins and thromboxanes;Coker;J Pharmacol Methods,1982

5. A radioimmunoassay for thromboxane B2;Fitzpatrick;Anal Biochem,1977

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patent Ductus Arteriosus in the Preterm Infant;Avery's Diseases of the Newborn;2024

2. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews;Cochrane Database of Systematic Reviews;2023-04-11

3. Impact of early screening echocardiography and targeted PDA treatment on neonatal outcomes in “22-23” week and “24-26” infants;Seminars in Perinatology;2023-03

4. Efficacy and safety of pharmacological treatments for patent ductus arteriosus closure: A systematic review and network meta-analysis of clinical trials and observational studies;Pharmacological Research;2019-10

5. Understanding the pathobiology in patent ductus arteriosus in prematurity—beyond prostaglandins and oxygen;Pediatric Research;2019-04-09